1-3 of 3
Eugenia Riveiro, MD, PhD
Close
Sort by
Journal Articles

The BET-Bromodomain Inhibitor OTX015 Is Active As a Single Agent and in Combination with Other Targeted Drugs in Preclinical Models of Mantle Cell Lymphoma

Elena Bernasconi, B.Sc., Chiara Tarantelli, Eugenio Gaudio, PhD, Ivo Kwee, Andrea Rinaldi, Luciano Cascione, Anastasios Stathis, MD, Maria Eugenia Riveiro, MD PhD, Emanuele Zucca, MD, Francesco Bertoni
Journal: Blood
Blood (2014) 124 (21): 3113.
https://doi.org/10.1182/blood.V124.21.3113.3113
Published: 2014
Journal Articles

BET Bromodomain Inhibitor OTX015 Affects the Expression of Micrornas Involved in the Pathogenesis of Diffuse Large B-Cell Lymphoma

Luciano Cascione, Eugenio Gaudio, PhD, Elena Bernasconi, B.Sc., Chiara Tarantelli, Andrea Rinaldi, Monica Testoni, B.Sc., Riccardo Bomben, Valter Gattei, Ivo Kwee, PhD, Anastasios Stathis, MD, Maria Eugenia Riveiro, MD PhD, Emanuele Zucca, MD, Francesco Bertoni
Journal: Blood
Blood (2014) 124 (21): 4495.
https://doi.org/10.1182/blood.V124.21.4495.4495
Published: 2014
Journal Articles

Preclinical Study Of The Bromodomain Inhibitor OTX015 In Acute Myeloid (AML) and Lymphoid (ALL) Leukemias

Thorsten Braun, MD, PhD, marie Magdelaine Coude, Pharm D, Jeannig Berrou, Sibyl Bertrand, Eugenia Riveiro, MD, PhD, Patrice Herait, MD, PhD, Andre Baruchel, MD, PhD, Hervé Dombret, Claude Gardin, MD
Journal: Blood
Blood (2013) 122 (21): 4218.
https://doi.org/10.1182/blood.V122.21.4218.4218
Published: 2013